ADAM J. COLE

Patent Agent
Intellectual Property

EXPERIENCE:

Dr. Adam Cole is a patent agent in the San Francisco office of Wilson Sonsini Goodrich & Rosati.

Adam has extensive training in pharmaceutical research, including pre-formulation and drug metabolism internships at Pfizer, Inc., and Eli Lilly & Co., respectively. Adam's doctoral thesis, completed at the University of Michigan College of Pharmacy, focused on improving the delivery of magnetically targeted, therapeutic iron oxide nanoparticles to brain tumors. As a result of this work, he has a high level of competency in nanoparticle chemistry and characterization, cancer therapy strategies, and in vivo tumor models.

Prior to joining the firm, Adam was a postdoctoral fellow at Stanford University, where he continued to study nanomaterials, this time as contrast agents in the early detection of cancer through the use of multi-modality molecular imaging.

EDUCATION:
  • J.D., UC Berkeley School of Law (Expected 2019)
  • Postdoctoral Fellowship, Molecular Imaging, Stanford University, 2012
  • Ph.D., Pharmaceutical Sciences, University of Michigan Ann Arbor, 2011
    American Foundation for Pharmaceutical Education National Predoctoral Fellowship, 2008-2011; President, Rackham Student Government; Co-founder, Student Advocates for Graduate Education (SAGE)
  • M.S., Pharmaceutical Sciences, University of Michigan Ann Arbor, 2007
  • B.S.E., Chemical Engineering, University of Michigan Ann Arbor, 2004
    Summa Cum Laude; Member, Tau Beta Pi National Engineering Honor Society; Member, Omega Chi Epsilon National Chemical Engineering Honor Society
SELECT PUBLICATIONS:
  • Co-author with L. Han, Y. Fu, J. Liu, and J. Wang, "Co-encapsulation and Sustained-Release of Four Components in Gingko Terpenes from Injectable PELGE Nanoparticles," 83 Fitoterapia 721-731, 2012
  • Co-author with A. David and V. Yang, "Magnetically Targeted Nanoparticles for Brain Tumor Therapy: What Does the Future Hold?" 6 Nanomedicine 1133-1135, 2011
  • Co-author with A. David, J. Wang, C. Galbán, and V. Yang, "Magnetic Brain Tumor Targeting and Biodistribution of Long-Circulating PEG-Modified, Cross-Linked Starch Coated Iron Oxide Nanoparticles," 32 Biomaterials 6291-6301, 2011
  • Co-author with V. Yang and A. David, "Cancer Theranostics: The Rise of Targeted Magnetic Nanoparticles," 29 Trends in Biotechnology 323-332, 2011
  • Co-author with A. David, B. Chertok, and V. Yang, "A Combined Theoretical and In Vitro Modeling Approach for Predicting the Magnetic Capture and Retention of Magnetic Nanoparticles In Vivo," 152 Journal of Controlled Release 67-75, 2011
  • Co-author with A. David, J. Wang, C. Galbán, H. Hill, and V. Yang, "Polyethylene Glycol Modified, Cross-Linked Starch-Coated Iron Oxide Nanoparticles for Enhanced Magnetic Tumor Targeting," 32 Biomaterials 2183-2193, 2011
  • Co-author with B. Chertok, A. David, and V. Yang, "Comparison of Electron Spin Resonance Spectroscopy and Inductively Coupled Plasma Optical Emission Spectroscopy for Biodistribution Analysis of Iron-Oxide Nanoparticles," 7 Molecular Pharmaceutics 375-385, 2010
  • Co-author with L. Zhang, F. Yu, B. Chertok, A. David, J. Wang, and V. Yang, "Gum Arabic-Coated Nanoparticles for Potential Application in Simultaneous Magnetic Targeting and Tumor Imaging," 11 AAPS Journal 693-699, 2009
  • Co-author with F. Yu, Y. Huang, and V. Yang, "The Artificial Peroxidase Activity of Magnetic Iron Oxide Nanoparticles and Its Application to Glucose Detection," 30 Biomaterials 4716-4722, 2009
ADMISSIONS
  • U.S. Patent and Trademark Office

Contact Information

One Market Plaza
Spear Tower, Suite 3300
San Francisco, CA 94105
Phone | 650-849-3298
Fax | 415-947-2099

Email | Adam Coleacole@wsgr.com


Areas of Expertise

Print to PDF